• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DYAX:US

9.8300 USD 0.0300 0.31%

As of 20:10:00 ET on 08/19/2014.

Snapshot for Dyax Corp (DYAX)

Open: 9.7900 Day's Range: 9.6100 - 9.8900 Volume: 529,019
Previous Close: 9.8000 52wk Range: 4.0300 - 10.9900 1-Yr Rtn: +135.17%

Stock Chart for DYAX

No chart data available.
  • DYAX:US 9.8200
  • 1D
  • 1M
  • 1Y
9.8000
Interactive DYAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1500
Est. EPS (USD) (12/2014) -0.1950
Est. PEG Ratio -
Market Cap (M USD) 1,338.90
Shares Outstanding (M) 136.21
30 Day Average Volume 987,356
Price/Book (mrq) 12.9883
Price/Sale (ttm) 18.7888
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYAX

Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.

Gustav A ChristensenPresident/CEOGeorge V MigauskyExec VP/CFO
Burt A AdelmanExec VP/Chief Medical OfcrAndrew AsheExec VP/General Counsel
More Company Profile & Key Executives for DYAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil